摘要
在世界范周内,肺癌已占所有癌症病死率的首位,十分迫切地需要新的治疗方法。肿瘤疫苗代表了一种低毒、高特异性的新治疗方法,作为一种极具发展前景的治疗方式有望为肺癌的治疗带来新的希望。近年来,越来越多的临床研究结果表明,免疫治疗应用于肺癌可以获得显著的临床疗效。本文就非小细胞肺癌的疫苗的研究现状及进展作一综述。
Since lung cancer is the leading cause of the cancer-associated death, new curative treatments are always desired in the clinic, Owing to its low toxicity and high specificity, tumor vaccines are gradually drawing people's attention as a new therapy providing lung cancer treatment a great prospect. Recently, increased evidence from clinical studies revealed that vaccines for lung cancer demonstrated a prominent clinical effect. This review aims to summarize the current situation and progression for the vaccines for non small cell lung cancer (NSCLC) patients.
出处
《国际呼吸杂志》
2012年第4期312-316,共5页
International Journal of Respiration
基金
江苏省医学重点人才课题(RC2007113)
基础研究计划(自然科学基金)(BK2008326)
关键词
非小细胞肺癌
肿瘤疫苗
免疫应答
Non-small cell lung cancer
Tumor vaccine
Immune response